Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Oftalmología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A 64-week, Two-arm, Randomized, Double-masked, Multicenter, Phase IIIb Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen in Patients With Neovascular Agerelated Macular Degeneration (TALON)
INTERVENTIONAL
Inicio: 25 de sept de 2019
ID: NCT04005352
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS 01 Eye Drops in Subjects With Diabetic Macular Edema
INTERVENTIONAL
Inicio: 15 de mar de 2024
ID: NCT06172257
Reclutando
Fase 1
ClinicalTrials.gov
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Non-arteritic Ischemic Optic Neuropathy
INTERVENTIONAL
Inicio: 1 de feb de 2022
ID: NCT05147701
Reclutando
ClinicalTrials.gov
A Multicentre Study Assessing Ophthalmic Safety in Patients With Breast Cancer
OBSERVATIONAL
Inicio: 4 de mar de 2025
ID: NCT06767462
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults With Macular Neovascularization Secondary to Age-Related Macular Degeneration
INTERVENTIONAL
Inicio: 22 de jul de 2025
ID: NCT07064759
Completado
ClinicalTrials.gov
Outcomes of Extensive Brilliant Blue G-Assisted Internal Limiting Membrane Peeling in Retinal Detachment With Proliferative Vitreoretinopathy Using 3D Visualization System
OBSERVATIONAL
Inicio: 20 de jul de 2020
ID: NCT04490876
Retirado
Fase 3
ClinicalTrials.gov
A Phase IIIb, Multicenter, Randomized, Visual Assessor-Masked Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
INTERVENTIONAL
Inicio: 29 de dic de 2023
ID: NCT05126966
Completado
ClinicalTrials.gov
Observational Study of Routine Ophthalmological Examinations of Patients Included in the 2 Bayer Sponsored Phase 3 Clinical Trials FIDELIO and FIGARO to Investigate the Effect of Finerenone on Delaying the Progression of Diabetic Retinopathy
OBSERVATIONAL
Inicio: 23 de jul de 2020
ID: NCT04477707
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista® (Anti PDGF-B Pegylated Aptamer) Administered in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy in Subjects With Subfoveal Neovascular Age-related Macular Degeneration.
INTERVENTIONAL
Inicio: 1 de may de 2014
ID: NCT01940887
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion
INTERVENTIONAL
Inicio: 2 de mar de 2021
ID: NCT04740905
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
INTERVENTIONAL
Inicio: 1 de may de 2011
ID: NCT01358266
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
INTERVENTIONAL
Inicio: 1 de ago de 2012
ID: NCT01684345
Completado
Fase 4
ClinicalTrials.gov
Efficacy and Safety of Difluprednate Ophthalmic Emulsion vs. a Fixed-Combination of Prednisolone Acetate - Phenylephrine Ophthalmic Suspension on Post-operative Inflammation Following Cataract Surgery.
INTERVENTIONAL
Inicio: 24 de mar de 2019
ID: NCT04631315
Completado
Fase 4
ClinicalTrials.gov
PHASE IV, MULTICENTRIC, DOUBLE-BLIND, RANDOMIZED, CONTROLLED,60 DAYS, PARALLEL GROUPS, SUPERIORITY STUDY, TO COMPARE THE EFFECTIVENESS AND TOXICITY OF BEPOTASTINE 1.5% PF vs. OLOPATADINE 0.2% WITH BAK IN TREATMENT OF ALLERGIC CONJUNCTIVITIS
INTERVENTIONAL
Inicio: 10 de mar de 2021
ID: NCT04776096
Terminado
Fase 3
ClinicalTrials.gov
LUMINA: A Phase III, Multicenter, Sham-Controlled, Randomized, Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye.
INTERVENTIONAL
Inicio: 19 de nov de 2018
ID: NCT03711929
Desconocido
Fase 2
ClinicalTrials.gov
Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy
INTERVENTIONAL
Inicio: 1 de jun de 2018
ID: NCT03542006
Completado
Fase 4
ClinicalTrials.gov
Phase IV, Multicenter, Double-blind, Randomized, Controlled, Parallel-group, Trial to Evaluate the Efficacy and Safety of Dozolamide 2%/Timolol 0,5% PF vs Dorzolamide 2%/Timolol 0,5% BAK-preserved in OAG or OH
INTERVENTIONAL
Inicio: 7 de mar de 2023
ID: NCT05857267
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
INTERVENTIONAL
Inicio: 4 de mar de 2021
ID: NCT04770545
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
INTERVENTIONAL
Inicio: 6 de oct de 2014
ID: NCT02247531
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
INTERVENTIONAL
Inicio: 2 de mar de 2021
ID: NCT04740931
Anterior
1
2
3
4
...
434
Siguiente
Filtros